Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 698, pseudogene (RNU6-698P) is a processed pseudogene in the human genome derived from the U6 small nuclear RNA (snRNA) gene[4][3]. U6 snRNA is an essential component of the spliceosome complex, catalyzing the excision of introns from pre-mRNA during splicing in the nucleus[1]. However, RNU6-698P itself is a noncoding, unexpressed copy of U6 snRNA produced by retrotransposition and is presumed to have no functional role as it does not produce a functional RNA or protein[3][4]. There is no evidence it acts as a therapeutic target, is involved in any molecular pathway, interacts with drugs, or serves as a biomarker. Its primary relevance is as a genomic marker of retrotransposition activity, not as a biological or pharmacological target[3][4]. Key clarifications: - This is a pseudogene, not an active gene, protein, or receptor. - It is not considered a therapeutic target. - It is not implicated in disease, biomarker usage, or pharmacology. - Its existence reflects genome evolution and transposon activity rather than biological function in splicing or disease[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 698, pseudogene (RNU6-698P).